Sign in
4

Changes in Ownership

IRulya Therapeutics Inc. Filed Acc 0001209191-23-057799

Director bought 57,369 shares at an average $1.01 ($58,134)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Lamond David Director 2023-12-05 Purchase +19,123 $1.01 $19,314 2,241,418 I
Lamond David Director 2023-12-06 Purchase +19,123 $1.02 $19,505 2,260,541 I
Lamond David Director 2023-12-07 Purchase +19,123 $1.01 $19,314 2,279,664 I
Open-market purchases · 57,369 sh · avg $1.01 · $58,134
Loading xslF345X05/doc4.xml…